The BoD of Athens Medical Center SA informs its shareholders the following:
1. The repeated extraordinary shareholders meeting that took place on the 18th of December 2006 decided the share capital increase of Euro852.500 through the issue of 2.750.000 new registered common shares of par value Euro0,31 each with no rights issue for a team of 94 medical doctors and special scientists that have expressed their interest to participate in the Company''s share capital. The issue price of each new share was at Euro1,95 each. After the aforementioned share capital increase the company''s share capital of Euro26.888.153,80 is divided into 86.735.980 common registered shares of par value Euro0,31 each. The total proceeds of this share capital increase are Euro 5.362.500,00. The difference between issue proceeds and par value of Euro 4.510.000,00 will increase the share premium account, in line with prevailing legislation and articles of association of the company.
2. The Company did not publish an information prospectus as according to the Capital Markets Committee there is no obligation to publish one if the offering is to less than 100 private individuals or legal entities per each country/member state, which are not special investors. Whereas in line with article 4 paragraph 2a of the same law for the commencement of trading of shares on a stock exchange, representing, for a period of 12 months, a percentage smaller than 10% of the total number of shares of the same class already listed on the same stock exchange
3. On the 30th of January 2007 in the registrar of Societe Anonymes there was decision K2-1206 of the Minister of Development which approved the amendment of article 5 of the articles of association of the company in line with the decision of the Extraordinary shareholders meeting for the increase of the share capital by Euro852.500 and the issue of 2.750.000 new common registered shares of Euro0,31 par value each and issue price of Euro 1,95. The difference of Euro4.510.000,00 will increase the share premium account.
4. The ASE BoD during its meeting on the 10th of May 2007 approved the commencement of trading of the 2.750.000 new common shares
5. On the 17th of May the Company's shares will be traded on the ASE with the new adjusted price, as described in the ASE regulation, currently in power. The company confirms that the new shares will be debited, on the commencement of trading day, to the accounts of the investors in held the SAT.
6. The new shares will be dematerialized and will be entitled to dividend for the 2006 fiscal year
7. For more information shareholders can contact the Company on 210.6287245 Mr Zerdilas, 210.6862454, Mrs Dourambei.